Further, HLA class II-dependent help from CD4-positive TILs might significantly support anti-tumor immune response [1] (the term TILs will be used throughout the manuscript describing the population of tumor infiltrating T-lymphocytes mainly consisting of CD3-, CD4- and CD8-positive cells). This evidence concerns the gene CD4 and neoplasm.